Invention Grant
US09382330B2 Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
有权
Pdia4，细胞因子衍生物的靶标，用于肿瘤诊断和治疗
- Patent Title: Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
- Patent Title (中): Pdia4，细胞因子衍生物的靶标，用于肿瘤诊断和治疗
-
Application No.: US13103845Application Date: 2011-05-09
-
Publication No.: US09382330B2Publication Date: 2016-07-05
- Inventor: Wen-Ching Yang
- Applicant: Wen-Ching Yang
- Applicant Address: TW Taipei
- Assignee: ACADEMIA SINICA
- Current Assignee: ACADEMIA SINICA
- Current Assignee Address: TW Taipei
- Agency: Intellectual Property Connections, Inc.
- Agent Hsiu-Ming Saunders
- Main IPC: A61K31/704
- IPC: A61K31/704 ; C07K16/40 ; A61K31/00 ; A61K31/337 ; A61K31/36 ; A61K31/4188 ; A61K31/713 ; A61K38/12 ; A61K45/06 ; G01N33/574
Abstract:
Methods of diagnosing cancer that are based in part on the findings that Pdia4 promotes cell growth, cell proliferation, and cell cycle are disclosed herein. Methods of using microvessel density as a surrogate marker and reducing tumor microvessel density in a subject are also enclosed herein.
Public/Granted literature
- US20110280809A1 PDIA4, TARGET OF CYTOPILOYNE DERIVATIVES, FOR TUMOR DIAGNOSIS AND TREATMENT Public/Granted day:2011-11-17
Information query
IPC分类:
